Corinnova
John Criscione, MD, PhD, Co-Founder and Chief Technology Officer, works as a consultant and is the Director of the Cardiac Mechanics Lab and Professor of Biomedical Engineering at Texas A&M University (TAMU). Dr. Criscione provides general consulting to the company, assisting in prototyping and pre-clinical animal studies as needed, and continues to make significant contributions to new inventions and key new patents relating to the core technology. Dr. Criscione earned his MD and PhD in Biomedical Engineering from Johns Hopkins University.
This person is not in any offices
Corinnova
Corinnova is commercializing a breakthrough technological platform for the treatment of congestive heart failure.